Filing Details

Accession Number:
0001209191-23-053939
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-31 16:11:28
Reporting Period:
2023-10-28
Accepted Time:
2023-10-31 16:11:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325710 L Matthew Sherman C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-28 8,244 $0.00 92,988 No 4 A Direct
Common Stock Disposition 2023-10-30 2,360 $12.02 90,628 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 8,244 RSUs.
  2. This sale was to cover tax liabilities in the vesting of RSUs.